Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P39
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -15.72% |
| Q3 2025 | 80.40% |
| Q2 2025 | 625.17% |
| Q1 2025 | -111.49% |
| Q4 2024 | -21.52% |
| Q3 2024 | 318.13% |
| Q2 2024 | 219.79% |
| Q1 2024 | -123.21% |
| Q4 2023 | 53.33% |
| Q3 2023 | 387.41% |
| Q2 2023 | -118.46% |
| Q1 2023 | 468.19% |
| Q4 2022 | -145.71% |
| Q3 2022 | 153.31% |
| Q2 2022 | -317.59% |
| Q1 2022 | 45.00% |
| Q4 2021 | -36.97% |
| Q3 2021 | 220.05% |
| Q2 2021 | -143.81% |
| Q1 2021 | 81.17% |
| Q4 2020 | 154.66% |
| Q3 2020 | -82.69% |
| Q2 2020 | 320.32% |
| Q1 2020 | 172.96% |
| Q4 2019 | -143.87% |
| Q3 2019 | 412.91% |
| Q2 2019 | 67.92% |
| Q1 2019 | -152.75% |
| Q4 2018 | 871.57% |
| Q3 2018 | 120.78% |
| Q2 2018 | -1676.10% |
| Q1 2018 | -81.47% |
| Q4 2017 | 5.65% |
| Q3 2017 | 1098.24% |
| Q2 2017 | -108.63% |
| Q1 2017 | 764.16% |
| Q4 2016 | 0.00% |